Sigma Healthcare Ltd (SIG)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 2.740 |
|---|---|
| 52-week range | 2.470 – 3.200 |
| Return, 1 month / 3 months | +7.0% / −3.8% |
| Return, 1 year / 3 years | −10.6% / +339.5% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 24.3% |
| Worst drawdown (1 year) | -19.7% |
| Average daily value traded | 49.67M AUD |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sigma Healthcare is an Australian pharmaceutical wholesaler and distributor that supplies medicines, health products and pharmacy merchandise to community pharmacies. It also runs pharmacy retail brands and provides support services to independent pharmacists, serving customers across Australia from its base in Melbourne. The company combines large-scale distribution with retail pharmacy operations, helping pharmacies stock and sell prescription medicines and everyday health and personal care products to their local communities.
Sigma Healthcare Ltd trades under the code SIG on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sigma Healthcare Ltd (SIG) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.740 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 272 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.6% and over the last three months it fell 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -2.0% | ||
| From 52-week high | -13.3% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.8% | ||
| 6-month return | -1.8% | ||
| 12-month return, skipping the last month | -16.5% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.7% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 49.67M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | +7.0% |
| 3 months | −3.8% |
| 6 months | −1.8% |
| 1 year | −10.6% |
| 3 years | +339.5% |
| 5 years | +413.6% |
Signals
| 50-day / 200-day average | 2.691 / 2.795 |
|---|---|
| Golden / death cross (60 days) | Death, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.062 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | AUD 0.0200 |
| 4 Mar 2026 | AUD 0.0200 |
| 2 Sep 2025 | AUD 0.0130 |
| 1 Oct 2024 | AUD 0.0050 |
| 28 Mar 2024 | AUD 0.0050 |
| 25 Sep 2023 | AUD 0.0049 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.